Rare heterozygous parkin variants in French early-onset Parkinson disease patients and controls
- PMID: 17766365
- DOI: 10.1136/jmg.2007.051854
Rare heterozygous parkin variants in French early-onset Parkinson disease patients and controls
Abstract
Background: Mutations in the parkin gene cause autosomal recessive early-onset parkinsonism. The effect of single heterozygous mutations in parkin is still unclear. The aim of this study was to evaluate the frequency of exonic parkin variants in a case-control study.
Methods: The parkin gene was screened for both point mutations and exon rearrangements in 172 French patients with Parkinson disease (PD) and 170 controls from the same population. Patients with single parkin variants were also screened for PINK1, DJ-1 and LRRK2 exon 41 mutations.
Results: 10 exonic sequence variations were identified, including 3 known polymorphisms and 7 rare heterozygous variants, 2 of which were novel. There were significantly more rare heterozygous variants in patients (n = 10) with early-onset PD than in controls (n = 2). Screening of PINK1, DJ-1 and LRRK2 exon 41 in the 10 patients heterozygous for parkin failed to identify a second causative mutation.
Conclusion: These results suggest that single parkin mutations increase the risk of early-onset PD, but the possibility of a second parkin mutation cannot be excluded.
Similar articles
-
Case-control study of the parkin gene in early-onset Parkinson disease.Arch Neurol. 2006 Apr;63(4):548-52. doi: 10.1001/archneur.63.4.548. Arch Neurol. 2006. PMID: 16606767
-
Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease.Neurogenetics. 2008 Oct;9(4):263-9. doi: 10.1007/s10048-008-0138-0. Epub 2008 Aug 15. Neurogenetics. 2008. PMID: 18704525
-
Parkin and PINK1 mutations in early-onset Parkinson's disease: comprehensive screening in publicly available cases and control.J Med Genet. 2009 Jun;46(6):375-81. doi: 10.1136/jmg.2008.063917. Epub 2009 Apr 6. J Med Genet. 2009. PMID: 19351622 Free PMC article.
-
[Molecular genetics of PINK1].Brain Nerve. 2007 Aug;59(8):831-8. Brain Nerve. 2007. PMID: 17713119 Review. Japanese.
-
Distribution, type, and origin of Parkin mutations: review and case studies.Mov Disord. 2004 Oct;19(10):1146-57. doi: 10.1002/mds.20234. Mov Disord. 2004. PMID: 15390068 Review.
Cited by
-
Pharmacological therapy in Parkinson's disease: focus on neuroprotection.CNS Neurosci Ther. 2011 Oct;17(5):345-67. doi: 10.1111/j.1755-5949.2010.00150.x. Epub 2010 Apr 23. CNS Neurosci Ther. 2011. PMID: 20438581 Free PMC article. Review.
-
Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study.J Int Neuropsychol Soc. 2011 Jan;17(1):91-100. doi: 10.1017/S1355617710001190. Epub 2010 Nov 24. J Int Neuropsychol Soc. 2011. PMID: 21092386 Free PMC article.
-
Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease.Am J Hum Genet. 2008 Apr;82(4):822-33. doi: 10.1016/j.ajhg.2008.01.015. Epub 2008 Mar 20. Am J Hum Genet. 2008. PMID: 18358451 Free PMC article.
-
Assessing the relationship between monoallelic PRKN mutations and Parkinson's risk.Hum Mol Genet. 2021 Mar 25;30(1):78-86. doi: 10.1093/hmg/ddaa273. Hum Mol Genet. 2021. PMID: 33448283 Free PMC article.
-
Twenty years since the discovery of the parkin gene.J Neural Transm (Vienna). 2017 Sep;124(9):1037-1054. doi: 10.1007/s00702-017-1742-7. Epub 2017 Jun 15. J Neural Transm (Vienna). 2017. PMID: 28620835 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
